NEOPLASMS,COLORECTAL
Clinical trials for NEOPLASMS,COLORECTAL explained in plain language.
Never miss a new study
Get alerted when new NEOPLASMS,COLORECTAL trials appear
Sign up with your email to follow new studies for NEOPLASMS,COLORECTAL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug shows promise for stubborn cancers
Disease control OngoingThis study tests a new drug called 9-ING-41, given alone or with chemotherapy, in adults with cancers that have not responded to standard treatments. The goal is to see if the drug is safe and can help control the disease. About 350 people with various advanced cancers, including…
Matched conditions: NEOPLASMS,COLORECTAL
Phase: PHASE2 • Sponsor: Actuate Therapeutics Inc. • Aim: Disease control
Last updated Jun 18, 2026 11:53 UTC
-
New combo therapy targets hard-to-treat KRAS G12C cancers
Disease control OngoingThis study tests a new drug called JDQ443 combined with other therapies in people with advanced solid tumors that have a specific genetic change called KRAS G12C. The goal is to find safe doses and see if the combinations can shrink or control the cancer. About 74 adults with lun…
Matched conditions: NEOPLASMS,COLORECTAL
Phase: PHASE1, PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 17, 2026 12:07 UTC
-
New pill targets aggressive tumors with genetic flaw
Disease control OngoingThis early-phase study tests an experimental oral drug (GSK4418959) in adults with advanced solid tumors that have specific genetic changes (dMMR or MSI-H). The drug works by blocking a protein (WRN) that these tumors need to survive. The study aims to see if the drug, alone or w…
Matched conditions: NEOPLASMS,COLORECTAL
Phase: PHASE1, PHASE2 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Jun 10, 2026 13:24 UTC